Navigation Links
Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
Date:12/3/2008

COLLEGEVILLE, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants and young children. Wyeth is seeking an indication for the prevention of pneumococcal disease (PD) caused by the 13 serotypes included in the investigational vaccine in infants and children from two months to five years of age. The review of the MAA will be coordinated by the EMEA for all 27 countries in the European Union, as well as Norway, Iceland and Liechtenstein.

PCV13 includes the 13 most prevalent pneumococcal serotypes associated with serious PD. Seven of these (4, 6B, 9V, 14, 18C, 19F and 23F) are included in Prevenar* (Pneumococcal saccharide conjugated vaccine, adsorbed) - - the current global standard in PD prevention in infants and young children. The six additional serotypes (1, 3, 5, 6A, 7F and 19A) are associated with the greatest burden of remaining invasive disease. Both Prevenar (also known as PCV7) and PCV13 use CRM197 -- an immunological carrier protein with a 20-year history of use in pediatric vaccines.

"Today's submission is an important milestone for Wyeth and underscores the company's commitment to help protect current and future generations from serious pneumococcal disease," says Emilio Emini, Ph.D., Executive Vice President, Vaccine Research and Development, Wyeth Pharmaceuticals. "Since its introduction, Prevenar has had a substantial impact on public health, dramatically reducing the rate of invasive pneumococcal disease where it is routinely used. Our investigational 13-valent pneumococcal conjugate vaccine is designed to broaden protection, with the pot
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
3. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
9. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
10. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
11. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... -- Breast-Specific Gamma Imaging (BSGI) has been ...for the detection of ductal carcinoma in situ (DCI... a molecular breast imaging technique that can see...r very early stage cancers. According to findings ...logical Society of North America (RSNA), BSGI is a...
(Date:11/30/2009)... The Eleventh Annual Southeastern ...the Charleston Place Hotel in the historic distric...heryl Liljestrand, Dr. Harry Guttman, and Dr. Jere..., will attend. SEBIO 2009 promises to bring innov...s, entrepreneurs, and service providers from aroun...
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Europe Ophthalmic Devices Investment Op... http://www.reportlinker.com/p0166515/Europe-Opht...nd-Forecasts-to-2015.html ,, Europe Ophthalmic...recasts to 2015 ,, Summary ,, This report ...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3ACT Announces Partnership With Gilead Sciences Inc 12883 1Nu Skin Enterprises to Announce Second Quarter 2009 Results 50675 1
...RANCISCO, Oct. 25 BiPar Sciences, Inc., a,private... cancer therapies,today announced molecular biomar...ARP (poly-ADP-ribose polymerase) protein in multip...rs. The research is the first,demonstration of PAR...,insight is being used to guide the clinical devel...
...nificant anti-tumor activity of combination IV bel...r reported -, - Oral belinostat demonstrated to be...tion of results from two NCI-sponsored clinical tr...ference call today at 5:00 p.m. ...5 CuraGen Corporation,(Nasdaq: CRGN ), a clinica...
Other Medicine Technology:BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 2CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 3CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 4CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 5CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 6CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 7CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 8CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 9
(Date:12/1/2009)...lif., Dec. 1 The first nutrition b...s acclaimed for its potential to forestall the rav..., (Photo: http://www.newscom.com/cgi-bin/prnh/20....com/cgi-bin/prnh/20091111/NY08935LOGO ) ,, Th...z, Inc. of Rancho Santa Fe, Calif. contains as muc...
(Date:12/1/2009)...1 , - At ECPA,s Food Supp...ion and Modes of Agriculture Will Require Science-...Chief Scientific Adviser to the UK government,ass... on science and have a,sound evidence basis. "Havi...ity to look at all stages of policy development ha...
(Date:12/1/2009)... may up chances of disease, study finds , ... may actually boost the risk of breast cancer in s...tch researchers analyzed six previously published ...iation exposure from mammography among women with ...nd two looking at the effect of radiation from scr...
(Date:12/1/2009)... study accepted for publication in The Endocrine S...bolism ( JCEM ), youth with type 1 diabetes have .... Having abnormal insulin resistance appears to n...function in this population. , Type 1 diabetes ...abetes have their insulin resistance measured rout...
(Date:12/1/2009)...NDIANAPOLIS, Dec. 1 Expr... Inc. (NYSE: WLP ), announced today the closing ...tRx subsidiaries. ,, (Logo: http://www.newsco...ogo: http://www.newscom.com/cgi-bin/prnh/2008082...des a 10-year agreement under which Express Script...
Breaking Medicine News(10 mins):Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance 2Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 2Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 3Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 4Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 5Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 6
...cornmeal with folic acid markedly reduces the numb...pina bifida, say researchers according to a new st...ake folic acid supplements in early pregnancy when...of neural tube defects in babies born in Newfoundl...
...fects more than 80 percent of teenagers and up to ...cited // as a source of acne, these claims have be...sity students participated in this study. Each par...re recorded using the Perceived Stress Scale, whic...
...are at a higher risk of developing restless legs s... urge to move the legs and is generally accompanie...ations. Patients also report an increase in sympto... Researchers say they found that pregnant study ...
...more likely to develop ischemic heart disease as a...ed //, according to a new study. Stressful childho...as smoking, drug abuse, and inactivity. This may c... physical neglect, or household dysfunction (i.e. ...
...sk for life-threatening cardiovascular diseases, p...ll // advised to monitor their blood sugar levels ... new study. Researchers conducted a meta-analys...that blood sugar levels play a role in the develop...
...best friend might be able to detect bladder cancer...gs can smell odors from malignant tumors in urine ...ere trained over seven months to discriminate betw...s and one bladder cancer patient. The dogs identif...
Other Medicine News:
ProtoCLAIMS
...'s DrWorks offering is a medical practice manageme... and interfaces. This medical practice management ...raphics, insurance company information, encounter ...nic claims filing capabilities, electronic claims ...
A.I.med's medical billing software
HCS INTERACTANT Application Financial System Solutions
Medicine Products: